COMS

Un listing de conférences scientifiques et techniques

Accueil | Logiciel de gestion de conférence | Calendrier des conférences | Annonces publicitaires | Nous contacter | Qui nous sommes
Deutsch Français English
Vous êtes ici: AccueilCalendrier des conférencesSoins de santé → Pharmacologie et développement des médicaments - États-Unis

Logiciel de gestion de conférences

Notre système de gestion de conférences en ligne (COMS) vous permet de:

  • gérer l'organisation de la conférence en ligne
  • gérer les inscriptions
  • gérer les paiements
  • gérer les soumissions de présentations
  • gérer la procédure de revue
  • sélectionner les présentations
  • produire le livre des résumés

Pour en savoir plus ...

Conférences - Pharmacologie et développement des médicaments - États-Unis

Conference-Service.com met à la disposition de ses visiteurs des listes de conférences et réunions dans le domaine scientifique. Ces listes sont publiées pour le bénéfice des personnes qui cherchent une conférence, mais aussi, bien sûr, pour celui des organisateurs. Noter que, malgré tout le soin que nous apportons à la vérification des données entrées dans nos listes, nous ne pouvons accepter de responsabilité en ce qui concerne leur exactitude ou étendue. Pensez donc à vérifier les informations présentées avec les organisateurs de la conférence ou de la réunion avant de vous engager à y participer!

Les organisateurs peuvent soumettre une réunion ou une conférence pour inclusion dans nos listes, et ceci gratuitement.

1.Polymers in Drug Delivery
 Dates 16 Sep 2014 → 17 Sep 2014
[ID=612337] Haut de la page
 LieuPhiladelphia, États-Unis
 Résumé The event focuses on parenteral drug administration (PDA), i.e. non-oral routes of pharmaceutical delivery including pre-filled syringes, bags, tubes, inhalers, and implants that leach active ingredients.
 Page web http://www.amiplastics-na.com/events/Event.aspx?code=C613&sec=4246
 Contact Stephanie Berchem; Tél.: [610 478 0800]; Email.: sb@amiplastics-na.com
 Sujets apparentés Chimie organique et polymères
  
2.Big DiP — Big Data in Pharma 2014
 Dates 16 Sep 2014 → 19 Sep 2014
[ID=633713] Haut de la page
 LieuBoston, États-Unis
 Résumé The 2nd annual Big DiP 2014 is packed with use cases and real results that cut through the big data hype and and shows what the future of of big data will look like.
 Page web http://big-datapharma.com/
 Contact Charlotte Parnaby; Tél.: [+44 203 141 8700]; Email.: info@hansonwade.com
  
3.BioPharm America™ 2014—7th Annual International Partnering Conference
 Dates 22 Sep 2014 → 24 Sep 2014
[ID=644514] Haut de la page
 LieuBoston, États-Unis
 Organisateur EBD Group
 Page web http://www.ebdgroup.com/bpa
  
4.Orphan Drugs — Orphan Drugs, Collaborations & Market Access Congress
 Dates 29 Sep 2014 → 30 Sep 2014
[ID=613028] Haut de la page
 LieuSan Diego, États-Unis
 Résumé The congress will bring together investors and experts in the orphan drug and rare disease space to share innovative research and best practice approaches to issues in R&D, clinical development, market access, pricing and reimbursement. Through an expert speaker panel, interactive forums, and a vibrant exhibition area, the meeting hopes to create long-lasting partnerships and solutions that help to address both the 7,000 rare diseases afflicting patients, market access challenges and opportunities and the financial implications of working in this field.
 Sujets Orphan Drugs, drug, discovery, R & D, research, market access, therapies, patient, investment, venture capital
 Page web http://www.globalengage.co.uk/orphan-drugs.html
 Contact Tél.: [0186 584 9841]; Email.: nnoakes@globalengage.co.uk
  
5.BABE-2014 — 5th World Congress on Bioavailabity and Bioequivalence: Pharmaceutical R&D Summit
 Dates 29 Sep 2014 → 01 Oct 2014
[ID=605078] Haut de la page
 LieuBaltimore, États-Unis
 Résumé BABE-2014 is a scientific avenue for people from diversified Pharmaceutical backgrounds, Academic Institutions, Healthcare Institutes, Pharmaceutical Regulatory Agencies, Biotech and Clinical Research Organizations making the congress a desirable platform where participants can communicate and mutually get benefited by sharing experiences about their respective fields of interest, build collaborations with research organizations, acquire benefits from interactive workshops, promote innovative styles, trends and advancements of Bioavailability and Bioequivalence.
 Page web http://babe2014.pharmaceuticalconferences.com/
 Contact John Benson , BABE-2014 Organizing Committee ; Tél.: [1-888-843-8169]; Email.: babe2014@omicsonline.us
  
6.Discovery on Target
 Dates 08 Oct 2014 → 10 Oct 2014
[ID=627369] Haut de la page
 LieuBoston, MA, États-Unis
 Résumé Cambridge Healthtech Institute will host its 12th Annual Discovery on Target event showcasing current and emerging "hot" targets for the pharmaceutical industry, October 8-10, 2014 in Boston, MA. Spanning three days, the meeting attracts over 900+ attendees (from 24 countries), composed of scientists/technologists, executives, directors, and managers from biopharma, academic, and healthcare organizations. In 2014 the event is comprised of 14 conference tracks which include Epigenetic Readers, Ubiquitin Proteasome, Big Data Discovery, GPCR Drug Discovery, RNAi-Screens-Functional-Genomics, PPI Targets, Protein-Targets, Histone-Methyltransferases-Demethylases, Drug Transporters, Maximizing Efficiency, GPCR Therapeutics, Genomics Screening, Cancer Metabolism and Membrane Production. The 2014 event will offer 200+ scientific presentations across 14 conference tracks, 1 Symposium and 15 conference short courses, 40+ interactive breakout discussion groups, an exhibit hall of 40+ companies, and dedicated poster viewing and networking sessions. The 12th Annual Discovery on Target assembles an impressive group of 195+ distinguished speakers who look forward to sharing their knowledge, best practices, and expertise with all attendees. The event website is www.DiscoveryOnTarget.com.
 Sujets drug discovery, pharmaceutical, drug target, epigenetic readers, ubiquitin proteasome, big data, GPCR, RNAi, functional genomics, protein targets, cancer metabolism
 Page web http://www.discoveryontarget.com
 Contact Kris Waterman; Tél.: [781-972-5400]; Email.: kwaterman@healthtech.com
  
7.Keystone Symposia – The Modes of Action of Vaccine Adjuvants
 Dates 08 Oct 2014 → 13 Oct 2014
[ID=625405] Haut de la page
 LieuSeattle, WA, États-Unis
 Sujets Vaccine Adjuvants, immunology
 Page web http://www.keystonesymposia.org/14S1
 Contact Attendee Services; Tél.: [800-253-0685, 970-262-1230]; Email.: info@keystonesymposia.org
 Sujets apparentés Biologie
  
8.The 5th Asia Clinical Triials Outsourcing Congress
 Dates 09 Oct 2014 → 10 Oct 2014
[ID=599503] Haut de la page
 LieuSan Diego, États-Unis
 Résumé This conference combines the previously independent China Clinical Trials Outsourcing Congress and Asia Clinical Trials Outsourcing Congress to address the subjects relevant to the region in a more coherent way. It is also co-located with the Asia Pharma R&D Outsourcing Congress which will look at the growing trend towards conducting earlier phases of discovery and pre-clinical studies in Asia.
 Sujets Clinical Trials, CROS, Pharmacovigilence, Outsourcing
 Page web http://www.clinical-trials-events.com/asia.html
 Contact Nick Noakes; Tél.: [+44 (0) 1865 849841]; Email.: nnoakes@globalengage.co.uk
 Sujets apparentés Essais cliniques
  
9.New Approaches to Cancer Drug Discovery
 Date de début14 Oct 2014
[ID=654616] Haut de la page
 LieuBoston, États-Unis
 Résumé New approaches to Cancer Drug Discovery is a one-day scientific symposium brought together to highlight the spectrum of new approaches and technologies being applied to oncology therapeutics of the future. The agenda will cover the spectrum of small molecule approaches to novel target groups (including epigenetic and metabolic), immunomodulation for oncology, messenger RNA therapeutics and novel nanotechnology engineering platforms. The day is aimed at scientists who wish to get a broad appreciation of the latest advances in cancer drug discovery delivered by key scientists from leading organizations.
 Sujets oncology, biotechnology, symposium, advances in cancer drug discovery, epigenetic, metabolic, immunomodulation, messenger RNA therapeutics, novel nanotechnology engineering
 Page web http://www.criver.com/cancer-symposia14/boston
 Contact W Spearing; Email.: biofocus@crl.com
 Sujets apparentés Cancérologie; Biotechnologie
  
10.MedicReS 4th World Congress on Good Medical Research
 Dates 16 Oct 2014 → 18 Oct 2014
[ID=575410] Haut de la page
 LieuNew York, États-Unis
 Page web http://www.medicres.org
 Contact Burak AKICIER; Email.: info@medicres.org
 Sujets apparentés Médecine (en général)
  
11.SPS 14th Annual Meeting — Safety Pharmacology Society 14th Annual Meeting
 Dates 19 Oct 2014 → 22 Oct 2014
[ID=625930] Haut de la page
 LieuWashington, DC, États-Unis
 Résumé The Safety Pharmacology Society (SPS) 14th Annual Meeting will be held October 19–22, 2014, in Washington, DC and will provide a dynamic forum for sharing the latest in safety pharmacology. The scientific program will offer in-depth discussions of relevant topics to keep you “in the know.” This meeting will feature a diverse range of scientific sessions organized into two tracks, covering issues such as, Cardiovascular, Central Nervous System, Non Cardiac Ion Channels, Respiratory, Regulatory, New Assays, Peripheral Neuropathy, and an all day Plenary on Wednesday covering the Updates and Perspectives on Comprehensive In Vitro Proarrhythmia Assay (CIPA). The meeting also will offer a full day of Continuing Education courses on October 19, both on an introductory level as well as advanced courses for the expert, and the Diplomate in Safety Pharmacology (DSP) Certification exam will be held the day before the meeting on October 18.
 Sujets Cardiovascular, Central Nervous System, Non Cardiac Ion Channels, Respiratory, Regulatory, New Assays, Peripheral Neuropathy, Comprehensive In Vitro Proarrhythmia Assay (CIPA)
 Page web http://www.safetypharmacology.org/AM2014/index.asp
 Contact Tél.: [7035470874]; Email.: spshq@safetypharmacology.org
  
12.65th American Association for Laboratory Animal Science National Meeting
 Dates 19 Oct 2014 → 23 Oct 2014
[ID=633479] Haut de la page
 LieuSan Antonio, États-Unis
 Page web http://nationalmeeting.aalas.org/
  
13.Drug Discovery USA Congress — Drug Discovery USA Congress
 Dates 21 Oct 2014 → 22 Oct 2014
[ID=629039] Haut de la page
 LieuBoston, États-Unis
 Résumé This congress brings together over 150 senior experts to discuss recent developments in drug discovery and medicinal chemistry. Topics covered include screening technology, drug design, assay development, external innovation access, computational chemistry and discovery informatics.
 Sujets Drug Discovery, Drug Design, Assay Development, External Innovation Access, Computational Chemistry, Discovery Informatics, Screening Technology
 Page web http://www.discoveryusa-congress.com/download-agenda-marketing/
 Contact Danielle Dalby; Tél.: [+44 (0) 1865 248455]; Email.: d.dalby@oxfordglobal.co.uk
  
14.PsychPharm — Psychopharmacology Update
 Date de début25 Oct 2014
[ID=631261] Haut de la page
 LieuCincinnati, États-Unis
 Résumé This activity is designed for child and adolescent psychiatrists, general psychiatrists, geriatric psychiatrists, nurse practitioners, physician assistants, nurses, psychologists, social workers, and other mental health professionals interested in treating patients with psychiatric disorders to remission with measurement based care.
 Page web http://www.psychpharmupdate.com/site/Default.aspx
 Contact Kim Kirchner , Registration Coordinator , Global Academy for Medical Education ; Tél.: [(502) 574-9023]; Email.: kkirchner@hqtrs.com
 Sujets apparentés Psychiatrie
  
15.VACC14 — 8th Vaccine & ISV Congress
 Dates 26 Oct 2014 → 28 Oct 2014
[ID=612985] Haut de la page
 LieuPhiladelphia, États-Unis
 Résumé Join us in Philadelphia for the premier conference on vaccines and vaccination. The 8th Vaccine & ISV Congress will feature science and public health topics, from primary vaccine research and vaccine manufacturers, to governmental policy, safety and regulation. If you work as a researcher in vaccine-related topics, in the vaccine industry, or in vaccine policy making, this is your must-attend event in 2014.
 Sujets Human vaccines - infectious diseases, Human vaccines - non-infectious diseases, Veterinary vaccines, Vaccine safety, Clinical studies and field trials, Immunology, animal models, Vectors, adjuvants, drug delivery, Production, manufacturing, Regulatory, societal, economic, programmatic, legislation subjects
 Page web http://www.vaccinecongress.com/
  
16.Re-Entering Antibacterial Drug Development Summit
 Dates 27 Oct 2014 → 29 Oct 2014
[ID=628958] Haut de la page
 LieuBoston, MA, États-Unis
 Résumé Several factors including diminishing financial return, lack of new discovery platforms and others, had a cooling effect on pharmaceutical companies' activity in the area of antibacterial drug development. At the same time, we are witnessing the wide spread of resistant bacteria, leading to untreatable infections. "We are facing a huge crisis worldwide not having an antibiotics pipeline," said Dr. Janet Woodcock, Director of CDER at FDA, in her recent interview to NYT. The governments of European countries and the United States have created several incentives for the industry to rise to the challenge. Therefore, many companies are exploring the opportunities to start or re-open their antibacterial departments, or to stimulate the existing research and development. Cambridge Healthtech Institute is pleased to present its inaugural Re-Entering Antibacterial Drug Development Summit that includes a science track and a business track, and features a wide range of pivotal issues. The Summit is designed as a forum for knowledge and opinion exchange between the major stakeholders shaping the current state of antibacterial discovery and development.
 Sujets drug development, antibacterial discovery, antibacterial development, discovery platforms, pharmaceutical, antibiotics, antibacterial departments, antibacterial research
 Page web http://www.healthtech.com/Antibacterial-Drug-Development
 Contact Kris Waterman; Tél.: [781-972-5400]; Email.: kwaterman@healthtech.com
  
17.Practical Approaches to Quality by Design (QbD) for Pharmaceutical Process Research, Development and Manufacturing
 Dates 27 Oct 2014 → 29 Oct 2014
[ID=629671] Haut de la page
 LieuBoston, Massachusetts, États-Unis
 Résumé This course focuses on practical approaches to accelerated QbD implementation, and it makes practical recommendations for realistic implementation of QbD elements. Participants will learn how to prioritize process parameters for screening designs, how to design robust processes using statistical design of experiments (DoE), how to bridge the bench and the commercial design spaces using mixing and scale-up calculations, how to quantify process risk, how to select suitable process analytical technology tools (PAT) and more. For the benefit of process scientists, engineers, formulators, analytical chemists and manufacturing personnel, this course includes highly interactive, hands-on workshops, based on several case studies. Effective technology transfer to pilot and manufacturing plants is also discussed, including process validation in the QbD paradigm.
 Sujets Organic Chemistry
 Page web http://www.scientificupdate.co.uk/training/scheduled-training-courses.html
 Sujets apparentés Génie chimique
  
18.2nd The Pharmacovigilance & Risk Management Strategies
 Dates 28 Oct 2014 → 29 Oct 2014
[ID=641812] Haut de la page
 LieuBoston, MA, États-Unis
 Résumé The Pharmacovigilance & Risk Management Strategies Conference is bringing together experts and industry leaders who will discuss the most important issues and challenges regarding Global Pharmacovigilance and Benefit-Risk Analysis. Some of the main topics will include the impact of the new EMA and FDA regulations, Social Media, Adverse Event Reporting, Signal Detection, and Benefit-Risk & Risk Management.
 Sujets pharmacovigilance drug safety drug development risk management pharmacovigilance strategies
 Page web http://pharma.americanleaders.com/pharmacovigilance-risk-strategies-east-forum?utm_source=listing_conference-service&utm_medium=listing&utm_campaign=ALLS10_home
 Contact Lawrence Smithson; Tél.: [+13125824273]; Email.: lawrence.smithson@americanleaders.com
 Sujets apparentés Législation en médecine et pharmacologie
  
19.Practical Approaches to Statistical Design of Experiments (DoE)
 Dates 30 Oct 2014 → 31 Oct 2014
[ID=629690] Haut de la page
 LieuBoston, Massachusetts, États-Unis
 Résumé This course takes a balanced approach presenting basic DoE theory as well as numerous examples of DoE use in the pharmaceutical industry. The course will discuss statistical and practical significance, assumptions and limitations of DoE methodology, together with practical approaches for the process scientist to be in control of the DoE investigation (and not the computer).
 Sujets Organic Chemistry
 Page web http://www.scientificupdate.co.uk/training/scheduled-training-courses.html
  
20.CHEMOTHERAPY FOUNDATION SYMPOSIUM: Innovative Cancer Therapy for Tomorrow®
 Dates 05 Nov 2014 → 07 Nov 2014
[ID=623100] Haut de la page
 LieuNew York, États-Unis
 Résumé CHEMOTHERAPY FOUNDATION SYMPOSIUM, Innovative Cancer Therapy for Tomorrow®, is a CME accredited educational activity jointly presented by the Icahn School of Medicine at Mount Sinai and the Chemotherapy Foundation, a non-profit organization supporting cancer research, in collaboration with The Tisch Cancer Institute. Founded in 1972 by Ezra Greenspan, we continue to bring the groundbreaking advances spearheading progress in cancer therapeutics to community and academic practitioners. Leading oncologist and hematologist investigators will report on new regimens, clinical trials and emerging therapeutic advances in common cancer types.
 Sujets Cancer, Chemotherapy, Oncology, Hematology, Breast Cancer, Gynecological Oncology, Surgical Oncologists, Pediatric Oncology, Radiotherapy, Immunology, Oncology Nurses, Case Managers, Pharmacists
 Page web http://www.chemotherapyfoundationsymposium.org/CMS/
 Contact Tél.: [212 866 2813]; Email.: Jaclyn.silverman@mssm.edu
 Sujets apparentés Cancérologie; Hématologie
  
21.2014 Chabner Colloquium: Collaboration in Cancer Drug Trials
 Dates 10 Nov 2014 → 11 Nov 2014
[ID=637771] Haut de la page
 LieuBoston, États-Unis
 Résumé The Society for Translational Oncology (STO) and the Massachusetts General Hospital Cancer Center (MGHCC), will host the 2014 Chabner Colloquium at The Liberty Hotel in Boston, Massachusetts on Monday-Tuesday, November 10-11, 2014. This meeting will focus on topics that bring cancer biology to clinical application and will feature a thoughtful look at the potential for collaboration between academia and industry with a focus on immuno-oncology and new therapeutic targets.
 Sujets Professional, Blood Cancer, Cancer Biology , Cancer, Diagnostics and Molecular Pathology, Clinical Pharmacology , Gastrointestinal Cancer, Genitourinary Cancer Prostate, Geriatric Oncology, Leukemias, Lung Cancer, Melanoma and Cutaneous Malignancies, New Drug Development and Clinical Pharmacology, Sarcomas, Lecture, Course
 Page web https://cme.alphamedpress.org/a/8608P7tA8e
 Contact Email.: CMEAdmin@sto-online.org
 Sujets apparentés Cancérologie; Essais cliniques
  
22.2nd International mRNA Health Conference
 Dates 11 Nov 2014 → 12 Nov 2014
[ID=639576] Haut de la page
 LieuCambridge, MA, États-Unis
 Résumé The 2nd International mRNA Health Conference, which will be held on November 11 and 12, 2014, in Boston, Massachusetts, will bring together more than 150 attendees from leading international pharmaceutical and biotechnology companies and academic institutions. During the two-day event, colleagues from around the world will share the vanguard of research and technologies poised to unlock the tremendous medical potential of mRNA for many therapeutic indications.
 Page web http://www.mrna-conference.com/
 Contact Victoria Drizin-Sirotin; Tél.: [Phone: +1 (617) 209-5835]; Email.: Victoria.Drizin-Sirotin@modernatx.com
  
23.3rd Pharmacovigilance & Risk Management Strategies
 Dates 11 Nov 2014 → 12 Nov 2014
[ID=642979] Haut de la page
 LieuSan Francisco, États-Unis
 Résumé The Pharmacovigilance & Risk Management Strategies Conference is bringing together experts and industry leaders who will discuss the most important issues and challenges regarding Global Pharmacovigilance and Benefit-Risk Analysis. Some of the main topics will include the impact of the new EMA and FDA regulations, Social Media, Adverse Event Reporting, Signal Detection, and Benefit-Risk & Risk Management.
 Sujets pharmacovigilance drug safety drug development risk management FDA regulations
 Page web http://pharma.americanleaders.com/pharmacovigilance-risk-strategies-west-forum?utm_source=listing_conference-service&utm_medium=listing&utm_campaign=ALLS11_home
 Contact Lawrence Smithson; Tél.: [+13125824273]; Email.: lawrence.smithson@americanleaders.com
 Sujets apparentés Législation en médecine et pharmacologie
  
24.2014 NEI Psychopharmacology Congress
 Dates 13 Nov 2014 → 16 Nov 2014
[ID=642827] Haut de la page
 LieuColorado Springs, États-Unis
 Page web http://www.neiglobal.com/go/congress
 Sujets apparentés Neurologie; Psychiatrie
  
25.FAST: Functional Analysis & Screening Technologies Congress
 Dates 17 Nov 2014 → 19 Nov 2014
[ID=632439] Haut de la page
 LieuBoston, MA, États-Unis
 Résumé Join our community of 250+ biologists, screening managers, assay developers, engineers and pharmacologists dedicated to improving in vitro cell models and phenotypic screening to advance drug discovery and development at 6 conferences: Phenotypic Drug Discovery (Part I & II), Engineering Functional 3D Models, Screening and Functional Analysis of 3D Models, Organotypic Culture Models for Toxicology and Physiologically-Relevant Cellular Tumor Models for Drug Discovery.
 Sujets drug discovery, toxicology, phenotypic, cellular tumor models
 Page web http://www.fastcongress.com
 Contact Kris Waterman; Tél.: [781-972-5400]; Email.: kwaterman@healthtech.com
  
26.Clinical Pharmacy-2014 — 2nd International Summit on Clinical Pharmacy
 Dates 02 Dec 2014 → 03 Dec 2014
[ID=613083] Haut de la page
 LieuSan Francisco, États-Unis
 Résumé Clinical Pharmacy-2014 is a unique event which forms a network with leading pharmacy doctors, researchers, industry professionals, scientists, pharmacists and scholar students to exchange and share their experiences, new ideas and research results about all aspects of Clinical Pharmacy and to discuss the practical challenges encountered and the solutions adopted.

2nd International Summit on Clinical Pharmacy provides opportunities for the delegates to exchange new ideas and new application experiences directly, to establish research relations and to find global partners for future collaboration. The scientific program paves a way to gather visionaries through the research talks and presentations and put forward many thought provoking strategies about Clinical Pharmacy. By attending this prestigious event you will be enlightened with innovative ideas and solutions and take initiatives to find better education in the biomedical, pharmaceutical, sociobehavioral and clinical sciences.

 Sujets General Clinical Pharmacology, Pharmacists Role in Patient Safety, Clinical Pharmacy and Its Key Role in Treatment, Dispensing Pharmacy and Research Chemists
 Page web http://clinicalpharmacy2014.pharmaceuticalconferences.com/index.php
 Contact Tél.: [1-650-268-9744]; Email.: clinicalpharmacy2014@omicsgroup.us
  
27.3rd Immunogenicity and Immunotoxicity Conference
 Dates 29 Jan 2015 → 30 Jan 2015
[ID=647324] Haut de la page
 LieuSan Diego, États-Unis
 Résumé GTC is proud to announce its 3rd Immunogenicity and Immunotoxicity Conference, one of four parallel tracks to the Novel Immunotherapeutics Summit 2015 on January 29-30, 2015 in San Diego, CA. The conference will cover important progress made in the areas of therapeutic protein immunogenicity and immunotoxicity evaluation such as protein aggregation, clinical relevance and assessment of immunogenicity, mitigation of immunogenicity-related risks, biosimilar development, and immunotoxicity evaluation strategies.

The Immunogenicity and Immunotoxicity Conference will provide guests with a better understanding of the ongoing research for tools to mitigate risks associated with the immunogenicity of therapeutic proteins. Guests will get an up-to-date understanding of the mechanisms and consequences of protein aggregation and insights on how to prosecute state-of-the-art assessment of the clinical immunogenicity of therapeutic proteins.

 Page web https://www.gtcbio.com/conferences/immunogenicity-immunotoxicity-overview
 Contact Tél.: [626-256-6405]; Email.: infogtcbio@gtcbio.com
  
28.Pharmacokinetics for Pharmaceutical Scientists Course
 Dates 02 Fév 2015 → 06 Fév 2015
[ID=651456] Haut de la page
 LieuSan Francisco, États-Unis
 Page web http://bts.ucsf.edu/pkcourse
  
29.SLAS 2015 — Conference and Exhibition of the Society for Laboratory Automation and Screening
 Dates 07 Fév 2015 → 11 Fév 2015
[ID=646949] Haut de la page
 LieuWashington, D.C., États-Unis
 Résumé The SLAS scientific program is geared especially towards life science research and development professionals whose interests include: drug discovery and development, assay development and screening, laboratory automation and high-throughput technologies, micro-nano technologies, molecular diagnostics and biomarkers, scientific informatics, bioanalytical techniques, and drug target biology. SLAS2015 offers participants a world-class scientific program that showcases the top laboratory science and technology podium presentations delivered by leading authorities from industry, academic and government backgrounds from around the world. Each podium presentation is diligently selected by the SLAS2015 Annual Conference Program Committee from hundreds of abstract submissions. These presentations offer SLAS2015 participants compelling content and new perspectives on emerging laboratory technologies customized for life science research and development professionals whose interests include: drug discovery and development,, assay development and screening,, laboratory automation and high-throughput technologies,, micro-nano technologies,, molecular diagnostics and biomarkers,, scientific informatics,, bioanalytical techniques,, and drug target biology..
 Page web http://www.slas2015.org/
 Sujets apparentés Physique appliquée: Biophysique et génie biomédical; Foire exposition chimie,
  
30.Molecular Med TRI-CON 2015
 Dates 15 Fév 2015 → 20 Fév 2015
[ID=638736] Haut de la page
 LieuSan Francisco, États-Unis
 Résumé The 22nd International Molecular Medicine Tri-Conference is the industry's Preeminent Event on Molecular Medicine, focusing on Drug Discovery, Genomics, Diagnostics and Information Technology. Spanning six days this year, the Tri-Conference includes an expanded program that includes 6 symposia, over 20 short courses, and 17 conference programs.
 Sujets biotech, biotechnology, information technology, diagnostics, genomics, drug discovery
 Page web http://www.triconference.com/
 Contact Kris Waterman ; Tél.: [(781-972-5400)]; Email.: kwaterman@healthtech.com
 Sujets apparentés Biotechnologie
  
31.EDD — Enzymes in Drug Discovery Conference
 Dates 25 Fév 2015 → 27 Fév 2015
[ID=650573] Haut de la page
 LieuSan Diego, Californie, États-Unis
 Résumé We welcome you to GTCbio's Inaugural Enzymes in Drug Discovery Conference, which will be held on February 25 - 27, 2015 in San Diego, CA.
 Sujets Enzyme Structures, Drug Targets
 Page web https://www.gtcbio.com/conferences/enzymes-drug-discovery-overview
 Contact Global Technology Community 635 W. Foothill Blvd, Monrovia, CA 91016 Phone: 626-256-6405 Fax: 626-466-4433 Email:infogtcbio@gtcbio.com; Tél.: [6262566405]; Email.: infogtcbio@gtcbio.com
  
32.Biotherapeutics Analytical Summitt
 Dates 09 Mar 2015 → 13 Mar 2015
[ID=639466] Haut de la page
 LieuBaltimore, États-Unis
 Résumé The first part of this conference focuses on Advances with Analytical Methods. Part Two of Analytical Characterization focuses on application of analytical technologies for a range of products including ADCs and multi-specifics.The Comparability for Biologics conference brings together scientists and engineers from core analytical lab, drug development, process sciences, formulation, manufacturing, QA/QC and regulatory affairs to share strategies, approaches and technologies that will help overcome these comparability questions and challenges.
 Sujets biotech, biotechnology, analytical methods, analytical characterization, analytical technologies, biologics
 Page web http://www.biotherapeuticsanalyticalsummit.com/bcc_homepage.aspx
 Contact Kris Waterman; Tél.: [781-972-5400]; Email.: kwaterman@healthtech.com
  
33.Pharma Nutrition 2015
 Dates 13 Avr 2015 → 15 Avr 2015
[ID=647800] Haut de la page
 LieuPhiladelphia, États-Unis
 Résumé Pharma-Nutrition is entirely dedicated to discussing the latest research, concepts and applications of medical nutrition in patient treatment and disease management. This conference will uniquely integrate the presentations on the role of the human microbiome and how it impacts both pharma and nutritional approaches in disease outcomes. This international conference is your opportunity to learn and share research, and to meet and network with your peers across the community of pharmacology, nutrition specialists and microbiome experts who work on the interface of pharma-nutrition.
 Page web http://www.pharma-nutrition.com/
 Sujets apparentés Chimie alimentaire et agronomie
  
34.Stress and Behavior — 5th International Regional "Stress and Behavior" Neuroscience and Biopsychiatry Conference (North America)
 Dates 22 Jui 2015 → 24 Jui 2015
[ID=633950] Haut de la page
 LieuMiami, États-Unis
 Résumé An annual international event gathering scientists and psychiatrists from around the world to share an interest in stress-evoked brain disorders in both humans and animals.
 Sujets stress, behavior, neuroscience, psychiatry, biopsychiatry, genetics, pharmacology, anxiety, mental health
 Page web http://www.scribd.com/doc/229265453
 Contact NA Nutsa, Conference Secretary , International Stress and Behavior Society; Tél.: [12408999571]; Email.: isbs.congress@gmail.com
 Sujets apparentés Psychiatrie
  
35.Gordon Research Conference — Drug Metabolism 2015
 Dates 12 Jul 2015 → 17 Jul 2015
[ID=647992] Haut de la page
 LieuHolderness, États-Unis
 Résumé The Drug Metabolism Gordon Research Conference (GRC) provides an intimate forum for the discussion of the diverse topics of this field. The meeting provides an ideal opportunity for young researchers to expand their scientific horizons, and graduate students and postdocs are encouraged to apply.
 Page web http://www.grc.org/programs.aspx?id=11186
 Sujets apparentés Biologie; Médecine (en général)
  
36.Gordon Research Conference — Computer Aided Drug Design 2015
 Dates 19 Jul 2015 → 24 Jul 2015
[ID=648095] Haut de la page
 LieuWest Dover, États-Unis
 Résumé The Gordon Research Conference on Computer-Aided Drug Design has been a premier conference in its field for more than three decades. During this period, there has been an ever-increasing interest in the application of computation to drug discovery, ranging from the all-atom simulation of molecular systems to the canonicalization and organization of molecular information. Some approaches, in particular molecular informatics, are now cornerstones of any drug discovery process. Statistics, data mining, machine learning and related concepts pervade today's drug discovery and development activities. An ever-important aspect of such research is the evaluation of progress: Is one method actually better than another? The program will be an unusual mix of cutting-edge, largely unpublished work in computational drug discovery, and lectures from experts outside the field who can give a broader view of the fundamental problems listed above and thus can illuminate the field’s greatest opportunities.
 Page web http://www.grc.org/programs.aspx?id=12080
 Sujets apparentés Modélisation moléculaire
  

États-Unis: liste de tous les évènements/conférences.

Dernière mise à jour: 16 septembre 2014